跳至主要内容
临床试验/NCT01413620
NCT01413620撤回1 期

Vitamin E Supplementation in Burn Patients

Shriners Hospitals for Children1 个研究点 分布在 1 个国家开始时间: 2011年8月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
撤回
试验地点
1
主要终点
Alpha-Tocopherol in Plasma, Adipose (also: Lung, Skin, Muscle, Liver in the case of Death)

研究概览

简要总结

Burned patients because of their increased oxidative stress have severely depleted vitamin E, which is a dietary antioxidant. Oxidative stress is responsible for much of the pathophysiology seen in burned patients, which leads to acute and chronic morbidity and mortality, in addition to a decrease in their quality of life. Oral vitamin E will be used to reverse the oxidative stress of burn injury and, in the process, decrease the secondary consequences of thermal trauma. This proposal will demonstrate the benefit of maintaining adequate vitamin E status.

详细描述

We have previously demonstrated that thermal injury depletes plasma vitamin E in pediatric burn patients. However, plasma changes reflect short-term vitamin E changes, whereas adipose tissue alpha-tocopherol concentrations reflect long-term vitamin E status. We reported last year that burn injury depleted vitamin E stores in adipose tissue in children by nearly half within one month following injury. Our long-term goal is to improve the quality of life of burn patients by preventing pulmonary and hepatic dysfunction that may occur from vitamin E depletion. The objectives of this application are to a) attenuate alpha-tocopherol depletion in burned patients by vitamin E supplementation, b) prevent or reverse oxidative stress in these patients, and c) collect pilot data on the effect of vitamin E supplementation on lung and liver function. Our central hypothesis is that the administration of high doses of alpha-tocopherol will prevent or restore levels of vitamin E in adipose tissue and reverse the oxidative state in burned patients. The rationale of the proposed studies is that in severe cases of vitamin E depletion, oxidative stress, fatty liver and lung dysfunction have all been reported in our patients. We will administer vitamin E supplements (300-1200 IU RRR-alpha-tocopherol) to burn subjects (n= 20 per group, 6-70 years, ≥20% total body surface burns) for fifteen days. The subjects will be randomly assigned into two groups: an early treatment group who will receive vitamin E for days 1-15 of the study, and a delayed treatment group who will receive vitamin E for days 16-30 of the study. Both groups will be studied for a total of thirty days. We will test the following aims: Aim 1: determine the degree that supplemental Vitamin E will attenuate alpha-tocopherol depletion. Aim 2: determine if supplemental Vitamin E reduces markers of oxidative stress in burned patients. Aim 3: collect preliminary data to establish the relationship between oxidative stress and pulmonary pathophysiology and fatty liver after burn injury. We will measure plasma and adipose tissue alpha-tocopherol and urinary and plasma markers of oxidative stress, prior to supplementation and then weekly. The proposed research is innovative because the oxidative stress of burn injury causes a severe depletion of an essential nutrient, vitamin E. Supplementation of vitamin E is a novel concept that may mitigate the complications of burns, including lung injury, fatty liver and peripheral neuropathy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
6 Months 至 85 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age: 6 months - 85 years
  • >20% TBSA burn

排除标准

  • Bleeding disorders
  • Positive hepatitis or HIV screens
  • Pregnancy (women)

研究组 & 干预措施

Vitamin E Treated

Experimental

干预措施: dl-alpha-tocopheryl acetate (Drug)

结局指标

主要结局

Alpha-Tocopherol in Plasma, Adipose (also: Lung, Skin, Muscle, Liver in the case of Death)

时间窗: 30 Days

Vitamin E Metabolites in Plasma, Urine

时间窗: 30 Days

Isoprostanes in Plasma, Urine (also: Lung, Skin, Muscle in the case of Death)

时间窗: 30 Days

Gamma-Tocopherol in Plasma, Adipose (also: Lung, Skin, Muscle, Liver in the case of Death)

时间窗: 30 Days

Malondialdehyde in Plasma, Urine (also: Lung, Skin, Muscle in the case of Death)

时间窗: 30 Days

Lipid Panel in Plasma and Triglyceride Concentration

时间窗: 30 Days

Liver Ultrasound

时间窗: 30 Days

Pulmonary Function Study Variables

时间窗: 30 Days

Cardiopulmonary Stress Test

时间窗: 30 Days

次要结局

  • Basal Metabolic Rate(30 Days)
  • Diet History and Food Intake(30 Days)
  • Fluid Balance(30 Days)
  • Open Body Surface Area and Wound Healing(30 Days)
  • Weight(30 Days)
  • Incidence of Acute Respiratory Distress Syndrome (ARDS)(30 Days)
  • Incidence of Pneumonia(30 Days)
  • Incidence of Atelectasis(30 Days)
  • Ventilator Variables (Compliance, Resistance, Work of Breathing, Number of Days Ventilated)(30 Days)
  • Pulmonary Status Variables (Spirometry, Blood Gas, Diffusion Constant, Pulmonary Capillary Surface Area)(30 Days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jong O. Lee

Assistant Professor of Surgery and Faculty Surgeon

Shriners Hospitals for Children

研究点 (1)

Loading locations...

相似试验

Vitamin E Supplementation in Burn Patients | 临床试验